THE EFFECT OF DONOR-SPECIFIC BLOOD TRANSFUSION, CYCLOSPORINE, AND DIET AR Y PROST AGLANDIN PRECURSORS ON RAT CARDIAC ALLOGRAFT SURVIVAL. II. Effectiveness of a 24-hour induction period with DST and CsA in Inducing Long-Term Graft Survival1
- 31 December 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 47 (1) , 177-181
- https://doi.org/10.1097/00007890-198901000-00037
Abstract
We investigated the effect of donor-specific transfusion given 24 hours pretransplant, a short course of low-dose cyclosporine, and dietary enrichment with the prostaglandin precursor linoleic acid (LA) to seen which of the modalities could act synergistically on cardiac allograft survival in a stringent animal model. ACI male rats (RT1a) were used a blood and heart donors, and Lewis male rats (RT1l) were used as recipients. DST alone (1 ml) given 24 hr pretransplant or LA alone started 24 hr pretransplant and given daily p.o. until rejection prolonged cardiac allograft survival slightly but significantly,from 6 to 8 days. CsA alone started at the time of transplant at a dose of 5 mg/kg/day s.c. and given daily for 14 days prolonged cardiac survival to 11.8 days. However, when CsA was started 24 hr pretransplant and continued for two weeks, there was a significantly prolonged allograft survival to 55 days. CsA given together with DST 24 hr pretransplant and continued for two posttransplant significantly prolonged cardiac allograft survival to 80 days and resulted in permanent tolerance in some animals. The addition of LA to a DST and CSA treatment regimen did not further improve allograft survival. CsA blood levels were determined in a separate group of Lewis rats. Three dosages of CsA were administered s.c. for 2 weeks: 2.5 mg/kg/day, 5 mg/kg/day, and 10 mg/kg/day. One injection of the three CsA doses did not achieve what are considered therapeutic levels in man. After 5 days, all three doses of CsA achieved significant blood levels. Significant blood levels were still present one week, but not 3 weeks after CsA was stopped. We conclude that DST given 24 hr before transplant and a 2-week course of low-dose CsA started one day pretransplant have strong synergism in inducing long-term graft survival in this rat model. Linoleic acid started 24 hr pretransplant, together with DST and CsA, did not contribute significantly to graft survival compared with the group given CsA and DST alone. Prolonged heart allograft survival was not due to persistently high CsA levels after the drug was discontinued.This publication has 16 references indexed in Scilit:
- A POTENTIAL SYNERGISTIC EFFECT OF DONOR ANTIGENIC EXTRACTS AND CYCLOSPORINE ON THE PROLONGATION OF RAT RENAL ALLOGRAFTSTransplantation, 1983
- PROSTAGLANDIN AS AN EFFECTIVE ANTIREJECTION THERAPY IN RAT RENAL ALLOGRAFT RECIPIENTSTransplantation, 1983
- Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.The Journal of Immunology, 1983
- Prostaglandin E inhibits the production of human interleukin 2.The Journal of Experimental Medicine, 1982
- EFFECT OF CYCLOSPORIN-A ON HUMAN-LYMPHOCYTE RESPONSES INVITRO .4. PRODUCTION OF T-CELL STIMULATORY GROWTH-FACTORS AND DEVELOPMENT OF RESPONSIVENESS TO THESE GROWTH-FACTORS IN CSA-TREATED PRIMARY MLR CULTURES1982
- Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination.Clinical Chemistry, 1981
- INDUCTION OF SUPPRESSOR CELLS BY DONOR-SPECIFIC BLOOD TRANSFUSIONS AND HEART TRANSPLANTATION IN RATSTransplantation, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.The Journal of Immunology, 1980
- IMMUNOSUPPRESSION WITH POLYUNSATURATED FATTY ACIDS IN RENAL TRANSPLANTATIONTransplantation, 1977